z-logo
Premium
Novel compound heterozygous mutation in LAMC 2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa
Author(s) -
Jeon In Kyung,
Kim SongEe,
Kim SooChan
Publication year - 2014
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.12413
Subject(s) - junctional epidermolysis bullosa (veterinary medicine) , missense mutation , epidermolysis bullosa , genetics , mutation , gene , compound heterozygosity , laminin , biology , heterozygote advantage , lamina lucida , microbiology and biotechnology , allele , extracellular matrix
Junctional epidermolysis bullosa ( JEB ) is a heritable blistering skin disease characterized by separation within the lamina lucida. It is caused by mutations in the LAMA 3 , LAMB 3 and LAMC 2 genes encoding the α3‐, β3‐ and γ2‐chains, respectively, of laminin‐332. JEB Herlitz type ( JEB ‐H) is a lethal blistering disease with severe cutaneous and extracutaneous involvements caused by null mutations in the gene encoding laminin‐332. Here, we report a proband with JEB ‐H who is a compound heterozygote for two novel mutations in LAMC 2 ; a missense mutation (c.79G>A) and an insertion mutation (382insT) leading to a premature termination codon.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom